MedTrace Logo

The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)

NCT01943903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 584

Last updated 2025-09-05

Study results available
· View outcomes & findings →

Summary

The objective of the PLATFORM Study is to compare clinical outcomes, resource utilization, and quality of life (QOL) of FFRCT-guided evaluation versus standard practice evaluation in patients with suspected CAD in order to further inform patients, health care providers, and other stakeholders about which technologies are most effective and efficient in the diagnosis of CAD

Conditions

Sponsors & Collaborators

  • Duke Clinical Research Institute

    collaborator OTHER

  • HeartFlow, Inc.

    lead INDUSTRY

Principal Investigators

  • Gianluca Pontone, MD · Centro Cardiologico Monzino

  • Pamela Douglas, MD · Duke University

  • Bernard de Bruyne, MD, PHD · Cardiovascular Center Aalst

  • Mark Hlatky, MD · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States
  • Austria
  • Belgium
  • Denmark
  • France
  • Germany
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01943903 on ClinicalTrials.gov